The size of the global market for devices used to Dry Eye Disease Treatment Devices was estimated at $299.1 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.5% from 2023 to 2030, or $537.5 million.
Dry eye is a tear film disease caused by decreased tear production or excessive evaporation of tears, which causes damage to the exposed ocular surface and causes eye pain and discomfort. The blockage or dysfunction of the Meibomian glands, which are situated in the eyelids and are responsible for generating the lipid layer of tears, causes excessive evaporation of tears and accounts for 86 percent of dry eye cases. Meibomian glands don't create enough oil in the tear film, which causes tears to evaporate more quickly. Increase in prevalence of dry eye disease, increased adoption of contact lenses, along with high time spent on visual display screens or digital devices leading to dry eye symptoms are major factors anticipated to drive the growth of the market. Moreover, rapidly growing elderly patient pool is at high risk of developing ocular disorders. All these factors are expected to boost the growth of dry eye disease treatment devices market in the next few years.
The global dry eye disease treatment devices market has been segmented based on technology, and region. Based on technology, the global dry eye disease treatment devices market is categorized into Broadband Light (BBL), Intense Pulsed Light (IPL), Meibomian Gland Expression (MGX), and Combination (MGX+IPL). Meibomian Gland Expression (MGX) segment held the largest share of global market in 2020. Geographically, North America dominated the global dry eye disease treatment devices market in 2020, however, Asia Pacific is expected to be the fastest growing region by 2028.
Key players operating in the global dry eye disease treatment devices market include ESW Vision, Lumenis, Johnson & Johnson Vision Care, Alcon, Inc., MiBo Medical Group, and Sight Sciences among others.
Dry Eye Disease Treatment Devices Market Scope
|Revenue forecast in 2030
|USD 537.5 Million
|CAGR of 7.5% during 2021-2030
|North America, Europe, Asia Pacific, South America, Middle East and Africa
|Key Players Profiled
|ESW Vision, Lumenis, Johnson & Johnson Vision Care, Alcon, Inc., MiBo Medical Group, and Sight Sciences among others.
Key Segments of the Global Dry Eye Disease Treatment Devices Market
Technology Overview, (USD Million)
- Broadband Light (BBL)
- Intense Pulsed Light (IPL)
- Meibomian Gland Expression (MGX)
- Combination (MGX+IPL)
Regional Overview, (USD Million)
- North America
- United Kingdom
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- South Africa
- Rest of Middle East & Africa
Reasons for the study
- Increase in prevalence of dry eye disease
- Growing demand for non-invasive treatment options
- Surging geriatric population across the globe
What does the report include?
- The study on the global dry eye disease treatment devices market includes qualitative insights such as drivers, restraints, challenges and opportunities
- Additionally, the market has been evaluated using the Porter’s Five Forces analysis
- The study covers qualitative and quantitative analysis of the market segmented on the basis of technology, and region.
- Actual market sizes and forecasts have been provided for all the above-mentioned segments
- The study includes the profiles of key players operating in the market
Who should buy this report?
- The report on the global dry eye disease treatment devices market is suitable for all the players across the value chain including raw material suppliers, hospitals & clinics, medical device manufacturers, healthcare organizations, ophthalmologists, distributors, suppliers and technology geeks
- Venture capitalists and investors looking for more information on the future outlook of the global dry eye disease treatment devices market
- Consultants, analysts, researchers, and academicians looking for insights shaping the global dry eye disease treatment devices market
Frequently Asked Questions (FAQ) :
Dry eye disease can have a significant impact on patient’s vision, comfort, and quality of life. Dry eye disease is divided into two categories by pathophysiological classification: aqueous deficient dry eye (ADDE) and evaporative dry eye (EDE), and this classification is frequently used to make diagnoses and choose treatment options. Tear film instability, hyperosmolarity, inflammation, and damage are major triggers of the dry eye disease. The ultimate goal of dry eye disease treatment is to interrupt the disease's vicious cycle and restore ocular surface and tear film equilibrium. Surging elderly patient pool suffering from ocular disorders is expected to drive the global dry eye disease treatment devices market. Increased adoption of multiscreen lifestyle by adults and children in developed and developing countries will drive the growth of the market in the coming years. Furthermore, development of new technologies will improve the clinicians’ ability to properly and efficiently diagnose dry eye which will have a positive impact on industry growth.
The global dry eye disease treatment devices market has been segmented based on technology, and region. Based on technology, the global dry eye disease treatment devices market is categorized into Broadband Light (BBL), Intense Pulsed Light (IPL), Meibomian Gland Expression (MGX), and Combination (MGX+IPL). Meibomian Gland Expression (MGX) segment held substantial share of the global market in 2020. Physical blockage of the meibomian glands, which stops the meibum from coming out to improve the stability of the tear film, is a typical problem with the meibomian glands. As a result, a variety of devices have developed on the market that employ heat and pressure to clear clogs. Intense pulsed light (IPL) segment is anticipated to grow at a significant rate during the forecast period. Intense pulsed light, was first created for use in dermatology. Short, intense bursts of light at specific wavelengths (in this example, between 500 and 800 nm) produce changes in blood vessels at the skin's surface, raise skin temperature, and eliminate harmful flora on the skin and eyes, all of which could help with meibomian gland dysfunction.
The global dry eye disease treatment devices market is cumulative to North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America dominated the global dry eye disease treatment devices market in 2020, however Asia Pacific is expected to grow at a rapid pace through 2028.
Increased prevalence of dry eye disease along with higher adoption of contact lenses, increased time spent on digital devices in the U.S. are major factors expected to drive the growth of the market in the region. It is estimated that, 1 in 6 adults in the U.S. wear contact lenses and approximately 73% users report dissatisfaction and or discontinuation due to dry eye symptoms. Furthermore, presence of large elderly patient population coupled with strong foothold of key industry players are other major factors likely to boost the growth of the market in North America.
However, Asia Pacific is expected to grow at a rapid pace over the next few years. There is a strong growth potential in the emerging economies such as India, and China. The rapidly rising geriatric population in countries such as India and China, increase in prevalence of ocular diseases along with high unmet clinical needs provide large market for dry eye disease treatment devices. Growing adoption of digital devices among adults and children in emerging countries leading to dry eye disease is further anticipated to boost the growth of the market in the coming years.